Published in Acta Neurol Scand on May 01, 2007
Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat (2011) 1.01
Infection after intracerebral hemorrhage: risk factors and association with outcomes in the ethnic/racial variations of intracerebral hemorrhage study. Stroke (2014) 0.95
Sensitization and tolerization to brain antigens in stroke. Neuroscience (2008) 0.93
Infections and ischemic stroke outcome. Neurol Res Int (2011) 0.82
Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial. Trials (2014) 0.80
Stroke: predicting the risk of poststroke epilepsy-why and how? Nat Rev Neurol (2010) 0.79
Correlation between inflammatory factors and post-stroke pneumonia in diabetic patients. Exp Ther Med (2013) 0.78
Age-based prediction of incidence of complications during inpatient stroke rehabilitation: a retrospective longitudinal cohort study. BMC Geriatr (2014) 0.77
Predictors of early infection in cerebral ischemic stroke. J Med Life (2016) 0.75
Pre-Stroke Use of Beta-Blockers Does Not Lower Post-Stroke Infection Rate: An Exploratory Analysis of the Preventive Antibiotics in Stroke Study. Cerebrovasc Dis (2016) 0.75
Relation of Urinary Retention and Functional Recovery in Stroke Patients During Rehabilitation Program. Ann Rehabil Med (2017) 0.75
Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. BMC Neurol (2016) 0.75
Infections Up to 76 Days After Stroke Increase Disability and Death. Transl Stroke Res (2017) 0.75
The influence of previous infections and antichlamydia pneumoniae seropositivity on functional outcome in ischemic stroke patients: results from the IN2 study. J Neurol (2015) 0.75
Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res (1983) 2.46
Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM (2006) 2.05
Phyllosphere microbiology with special reference to diversity and plant genotype. J Appl Microbiol (2008) 1.62
Expression of ras oncogene p21 in prostate cancer. N Engl J Med (1986) 1.35
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics (1998) 1.25
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res (1996) 1.06
Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique. Science (1981) 1.01
Identification of quantitative trait loci for resistance to Xanthomonas campestris pv. campestris in Brassica rapa. Theor Appl Genet (2006) 0.99
A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess (2002) 0.99
Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review. QJM (2004) 0.99
Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis? Intern Med J (2012) 0.92
A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression. Eur J Surg Oncol (1998) 0.91
Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells. Br J Cancer (1999) 0.91
Neurology of Fabry disease. Intern Med J (2007) 0.89
Age over 80 years is not associated with increased hemorrhagic transformation after stroke thrombolysis. J Clin Neurosci (2012) 0.88
The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics (1998) 0.84
Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival. Int J Gynecol Cancer (2001) 0.84
Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6. Pharmacogenetics (1998) 0.83
Mapping of functional activity in brain with 18F-fluoro-deoxyglucose. Semin Nucl Med (1981) 0.81
Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression. Br J Cancer (1996) 0.78
The development of the vibrissal cortical column: a 2-deoxyglucose study in the rat. Neurosci Lett (1984) 0.78
Identification of a novel missense mutation L329I in the episodic ataxia type 1 gene KCNA1--a challenging problem. Hum Mutat (2000) 0.75
Photoperiod effect on bud burst in Prunus is phase dependent: significance for early photosynthetic development. Tree Physiol (1996) 0.75
Prediction of outcome after stroke. Lancet (2001) 0.75
[Immunohistologic and molecular genetic studies of the effect of glutathione-S-transferases on the development of squamous epithelial carcinomas in the area of the head-neck]. Laryngorhinootologie (1999) 0.75
Early development of changes in cortical representation of C3 vibrissa following neonatal denervation of surrounding vibrissa receptors: a 2-deoxyglucose study in the rat. Neurosci Lett (1984) 0.75
Computer-assisted three-dimensional and two-dimensional reconstructions of autoradiographic images of the cerebral cortex. J Neurosci Methods (1984) 0.75